Glycine is an inhibitory neurotransmitter and is critical for NMDA receptor activation. These roles are dependent on extracellular glycine levels, which are regulated by Na + /Cl --dependent glycine transporters (GlyTs) in neurons and glia. The glial GlyT subtype GlyT1 is well-located to activate NMDA receptors.
ABSTRACT
Glycine is an inhibitory neurotransmitter and is critical for NMDA receptor activation. These roles are dependent on extracellular glycine levels, which are regulated by Na + /Cl --dependent glycine transporters (GlyTs) in neurons and glia. The glial GlyT subtype GlyT1 is well-located to activate NMDA receptors.
However, glial GlyTs have not been studied in an intact system thus far. Whole-cell patch-clamp recordings were obtained from Bergmann glia in mice cerebellar slices to determine whether these glia express functional GlyT1 that can mediate both glycine uptake and efflux. In the presence of a glycine receptor blocker, glycine and a substrate agonist for GlyT1, sarcosine, induced voltage-dependent inward currents that were abolished by removing external Na + , identifying them as transport currents. Inhibitors of glycine transport through GlyT1 (sarcosine and NFPS) reduced glycine currents by ~85%, consistent with positive immunostaining for GlyT1 in Bergmann glia while inhibitors of glycine transport through GlyT2 (ORG 25543 and amoxapine) or through systems A and ASC did not affect glycine transport currents. Following internal glycine perfusion during the recording, outward currents progressively developed at -50 mV and external glycine-induced uptake currents were reduced. Using paired recordings of a Bergmann glial cell and a granule cell in the whole cell and outside-out modes, respectively, depolarizations of Bergmann glia to +20 mV induced a 73% increase in the open probability of glycine receptor channels in membrane patches of granule cells. This increase was prevented when NFPS was included in the bath solution. Overall, these results demonstrate for the first time that Bergmann glia express functional GlyT1 that can work in reverse at near-physiological ionic and internal glycine conditions in brain slices. These glial GlyTs can likely mediate glycine efflux under conditions of metabolic impairments like ischemia.
INTRODUCTION
Glycine transporters (GlyTs) have been suggested to play an important regulatory role at glycine receptorcontaining synapses by clearing glycine from the synaptic cleft, and at synapses containing NMDA receptors (NMDARs) by keeping the extracellular glycine levels below saturating concentrations at the glycine site on NMDARs (Wood, 1995; Supplisson & Bergman, 1997; Parsons et al., 1998; Gomeza et al., 2003a, b) . Glycine as well as D-serine function as obligatory co-agonists by acting on a strychnine-insensitive site of NMDARs (glycineB site) (Johnson & Ascher, 1987; Kleckner & Dingledine, 1988; White et al., 1989; Mayer et al., 1989; Thomson et al., 1989; Schell et al., 1997; Baranano et al., 2001) . Glycine binding to the glycineB site has also recently been shown to prime NMDA receptor internalization (Nong et al., 2003) . Although there is still some debate whether the glycineB site is saturated in vivo, it is possible that GlyTs can keep locally extracellular glycine levels below saturating concentrations at the glycineB site because GlyTs are colocalized with NMDARs (Smith et al., 1992) . This likely depends on regional differences in NMDAR subtype expression and local glycine synthesis/metabolism ( Wood, 1995; . It has also been suggested that reverse glycine transport could result in increased glycine levels at NMDAR-containing synapses (Roux & Supplisson, 2000) . Such a Ca 2+ -independent glycine release has been shown to occur from cultured cerebellar astrocytes under high K + stimulation (Holopainen & Kontro, 1989) and from hippocampal slices under physiological, high K + stimulation or various pathological conditions such as ischemia (Saransaari & Oja, 1994; Saransaari & Oja, 2001) . Interestingly, an enhancement of ischemia-induced damage could be obtained in vivo with exogenous glycine, suggesting that the glycineB site was not saturated under these conditions (Dalkara et al., 1990) .
Two GlyTs have been cloned, GlyT1 and GlyT2 (Guastella et al., 1992; Smith et al., 1992; Liu et al., 1993; Morrow et al., 1998) , that are expressed in astrocytes and in neurons, respectively (Zafra et al., 1995; Adams et al., 1995) , and are members of the Na + /Cl --dependent transporter superfamily (Liu et al., 1993; Aragon et al., 1987) . GlyT1 is widely expressed in the CNS whereas GlyT2 has a more limited distribution and is colocalized with inhibitory glycine receptors (Zafra et al., 1995) . The glial GlyT1s
have been shown to be colocalized with NMDARs in rat brain (Smith et al., 1992) and influence NMDAR function in acute brainstem and hippocampal slices (Supplisson & Bergman, 1997; Bergeron et al., 1998) as well as in the hippocampus and prefrontal cortex in vivo (Kinney et al., 2003; Chen et al., 2003) . Furthermore, GlyT1 can take up or release glycine depending on the Na + and glycine concentrations, and the membrane potential (Sakata et al., 1997; Roux & Supplisson, 2000) while GlyT2
has a thermodynamic constraint for reverse transport, thus limiting glycine release. Although glia have been shown to contain ~2 mM glycine (Berger et al., 1977) , it is still unknown whether GlyTs in glia can work in reverse.
Bergmann glial processes, which totally ensheath Purkinje neuron soma and dendrites, have been shown to express GlyT1 by in situ hybridization and immunostaining in rats (Guastella et al., 1992; Zafra et al., 1995) . However, no functional characterization of GlyT currents has been performed in Bergmann glia in slices thus far. Therefore given the important function of GlyT1 at tightly regulating glycine levels and the potential for control of NMDAR-containing synaptic transmission by GlyT1, we undertook to determine whether Bergmann glia possess functional GlyT1. Furthermore, we questioned whether
Bergmann glial GlyTs could mediate glycine efflux. The results of this study will help to elucidate the physiological and pathological functions of glial GlyT1 in the CNS.
MATERIAL AND METHODS
Slice preparation: Cerebellar slices were prepared as previously described (Bordey & Sontheimer, 2000; . Briefly, 10-to 23-day old mice were anesthetized using pentobarbital (50 mg/kg) and decapitated. A rapid craniotomy allowed the cerebellum to be quickly detached, removed and chilled (0-4°C) in 95% O 2 / 5% CO 2 saturated artificial cerebrospinal fluid (ACSF) containing (in mM): NaCl 125; KCl 2.5; CaCl 2 2; MgCl 2 2; NaHCO 3 25; glucose 10. Next, the cerebellum was glued to the stage of a vibratome and transversal slices (250 µm thick) were cut in cold oxygenated ACSF. After a recovery period of >1 hour in ACSF, slices were placed in a flow-through chamber, held in position by a nylon mesh glued to a U-shaped platinum wire and continuously superfused with oxygenated ACSF at room temperature. The chamber was mounted on the stage of an upright microscope (Olympus BX50) equipped with a 60x water immersion objective and infrared optics.
Electrophysiology and drug application: Whole-cell patch-clamp recordings were obtained as previously described (Bordey & Sontheimer, 2000; (Bordey & Sontheimer, 2000) . To permit reversal of glycine transporters, HEPES sodium salt was used instead of HEPES, 4 mM glycine was added, and 4 mM KCl was removed (26 mM instead of 30 mM). The pH of the internal solution was adjusted with NaOH, which introduced 2.5 mM Na + and resulted in an internal
[Na + ] of 12.5 mM, close to reported physiological values in astrocytes (Rose & Ransom, 1996a) . Wholecell recordings were performed using an Axopatch-200B amplifier (Axon Instruments). Current signals were low-pass filtered at 2-5 kHz and digitized on-line at 5-20 kHz using a Digidata 1320 digitizing board (Axon Instruments) interfaced with an IBM-compatible computer system. Data acquisition, storage and analysis performed using PClamp version 8.0.2 (Axon Instruments). Settings were determined by compensating the transients of a small (5 mV) 10 ms hyperpolarizing voltage step. The capacitance reading of the amplifier was used as value for the whole-cell capacitance. Bergmann glia exhibiting a Cm<20 pF were disregarded. The resting potential and input resistance were determined in the first 3 min of whole-cell recordings. Capacitive and leak conductances were not subtracted. Peak currents were determined using Clampfit (Axon Instruments), and statistical values (mean ± SEM, with n being the number of cells tested) were evaluated with a statistical graphing and curve-fitting program (Origin, MicroCal). To quantify the effect of several drugs on glycine uptake currents, the amplitudes of glycine uptake currents were measured before and then during application of a drug. Receptor and transporter inhibitors were diluted in ACSF and applied by regular bath perfusion or a rapid bath application system composed of a 6-channel-mini-valve perfusion system (Warner Instruments
Corp., New Haven, CT). Glycine was occasionally applied by this rapid application system. Transporter substrate agonists were pressure applied by a computer-controlled pressure ejection system and were diluted in ACSF, in which HEPES replaced NaHCO 3 and pH was adjusted to 7.4 by NaOH. When NaCl was replaced by choline or another chemical, similar changes were performed in the pressure pipette solution. The pressure ejection pipettes were standard unpolished patch electrodes with resistances of 6-8 MΩ for local agonist application and were positioned just above the slice. The applied pressure was between 3-6 Psi. For application of two drugs to the same cell, theta glass pipettes with one distinct drug in each compartment were used.
Intracellular perfusion of glycine during the recording: Intracellular perfusion of glycine was performed as we previously reported (Myers & Haydon, 1972; Kyrozis & Reichling, 1995) . The gramicidin-containing solution was prepared fresh for each experiment, diluted in prefiltered intracellular solution to yield a final concentration of 5 µg/ml. To ensure full efficacy of the gramicidin, the solution was protected from light and renewed every 2 hours. The liquid junction potential (4.5 mV) was corrected. Patch pipettes had a resistance of 5-6 MΩ when filled with the intracellular solution. Two precautions were used to minimize gramicidin ejection from the patch pipette when approaching the cells: positive pressure was avoided as possible and the pipette tip was filled with the normal intracellular solution by 15-25 sec dipping (the gramicidin-containing solution was added by regular filling). After seal formation, the progress of perforation was followed by applying a ramp protocol every 30 sec. Stable perforated recordings (<45 MΩ series resistances, mean of 30.1 ± 3.9 MΩ before compensation of 60-70%, n=7) were obtained after >30 min (mean of 39.6 ± 4.3 min).
GlyT1 and GlyT2 immunostainings: 16-19 day old CD1 mice (n=3) were anesthetized with sodium pentobarbital (100 mg/kg) and then fixed by transcardiac perfusion with 4% paraformaldehyde (PFA) in phosphate-buffered saline (PBS; 0.1 M phosphate buffer, 9% NaCl) at pH 6.5 for 5 minutes, followed by 4% PFA in PBS at pH 10.5 for 15 minutes. The brains were removed and postfixed in the second perfusate for 24 hours at 4°C. All tissue was mounted in 2% agarose and sectioned on a vibratome into 20 µm sagittal sections. Slices were washed three times in PBS, permeabilized for 20 min with 0.3% Triton X-100, rinsed three times with PBS, and then blocked overnight at 4ºC in PBS containing 1% bovine serum albumin, 10% goat serum, and 0.3% triton. Slices were incubated overnight at 4°C with primary goat and sheep antibody against GlyT1 and GlyT2, respectively, (1:1000, Chemicon) in blocking solution. 
RESULTS
Whole-cell recordings were obtained from 132 visually identified Bergmann glia in cerebellar slices and 8
granule cell patch and Bergmann glial cell simultaneous recordings from 10-23 day-old mice. We used 14 to 23 day old animals to study GlyTs in Bergmann glia because GlyT1 and GlyT2 are already highly expressed in the cerebellum and have almost reached adult values (Zafra et al., 1995) . In addition, during this age period NMDA receptor activation is known to significantly influence GABA release at GABAergic interneuron-Purkinje neuron synapses (Glitsch & Marty, 1999; Huang & Bordey, 2004) . We performed paired recording experiments in slices from P10-13 mice because more granule cells expressed glycine receptors in slices from P10-13 (~80%, n=12) than in slices from older animals (~55%, data not shown, n=10). Bergmann glia were identified by the location of their cell body in the Purkinje cell layer and by the small size of their somata (8-12 µm diameter) in comparison to the large cell bodies of Purkinje neurons (Fig. 1A ). Every cell recorded in the whole cell configuration was filled with lucifer yellow and identified as a Bergmann glial cell by a typical morphology characterized by long, parallel processes extending in the molecular layer toward the pial surface ( Fig. 1B ) (de Blas, 1984; Reichenbach et al., 1995) . In addition, recorded cells had a characteristically low mean input resistance of 34.5 ± 1.0 MΩ, (n=109, mean ± SEM), a mean hyperpolarized resting membrane potential (V R ) of -79.3 ± 0.6 mV (n=109), and displayed a passive current profile (data not shown).
Characterization of glycine uptake currents in Bergmann glia
For all of the following experiments, Bergmann glia were recorded at a holding potential of -70 mV in the presence of 1 µM tetrodotoxin (TTX) in the external solution to prevent action potential-induced transmitter release from surrounding neurons. Pressure (5 sec) or rapid bath (30 sec-1 min) applications of glycine (500 µM) induced inward currents with mean amplitudes of -39.4 ± 3.8 pA (n=39/44) and 41.0 ± 4.2 pA (n=24/27) when recorded with a high and low KCl intracellular solution, respectively. For the study of the glycine uptake currents, cells were recorded with a high KCl solution unless otherwise noted.
Glycine-induced currents could be the result of glycine receptor activation and/or Na + -dependent glycine transport systems (Guastella et al., 1992; Smith et al., 1992; Liu et al., 1993; Morrow et al., 1998) . Bath application of strychnine (100 µM), a well-known blocker of glycine receptors, had no effect on glycine- were recorded with a low KCl internal solution (n=6, Fig. 7 ). In order to ensure the suitability of the pressure application method, we used a theta glass pipette to sequentially pressure apply glycine and betaine onto the same cells. Betaine, which is a substrate agonist of GABA transporter BGT-1/GAT2 Matskevitch et al., 1999) , is not transported into Bergmann glia . In this condition, pressure applications of glycine induced inward currents while betaine had no effect (Fig. 1F, n=3 ). When cells were recorded with a CsCl-based intracellular solution, the mean amplitude of strychnine-insensitive currents averaged -37.4 ± 8.0 pA (n=5, data not shown), which was not significantly different from that in cells recorded with a KCl-based intracellular solution (mean of -39.4 ± 3.8 pA, n=39). This result was expected because K + is not thought to be required for glycine transport as previously shown for the transport of other inhibitory amino acids such as GABA and taurine via Na + /Cl -dependent transporters (Borden, 1996; .
Ion-and voltage-dependence of glycine-induced currents in Bergmann glia:
GlyTs depend on Na + and Cl -for glycine uptake (Aragon et al., 1987; Guastella et al., 1992; Liu et al., 1993) . Fig. 2A shows that when Na + was removed from the extracellular solution (Na + was replaced by choline or Li + , n=5, data not shown), strychnine-insensitive glycine currents were reversibly and completely blocked, identifying them as glycine-induced transport currents. Lowering extracellular [Cl - ] from 136 to 11 mM (NaCl was replaced with NaGluconate) significantly (p<0.03) reduced glycine-induced transport currents by 78.0 ± 3.5% (n=3, Fig. 2B ). When the cell membrane was gradually depolarized from -70 to +50 mV, glycineinduced transport currents display prominent inward rectification and did not reverse for positive membrane potentials up to +50 mV in our recording conditions ( Fig. 2C and 2D (Borden, 1996; . For these experiments and those to determine the voltage-dependence of transport reversal, glycine was locally applied onto the cell body and proximal processes to limit any error associated with a poor voltage clamp of distal processes. Such a method has given accurate measurements of the current-voltage (I-V) curve for GABA and taurine transport currents in similar conditions . Together these data strongly suggest that glycine-induced currents in the presence of strychnine are generated by glycine being taken up into Bergmann glia.
Immunostaining for GlyT1 and GlyT2: Both GlyT1 and GlyT2 were expressed in the Purkinje cell layer and the molecular layer of the cerebellum. GlyT1 was highly expressed in the cell bodies and processes (arrows in Fig. 3A ) of Bergmann glia that displayed endfeet on the pial surface. Weak cytoplasmic GlyT1 was present in Purkinje neuron dendrites (arrowhead, fig. 3A ). GlyT2 stained mostly in the upper part of the molecular layer. GlyT2 weakly stained some presumed glial fibers (arrows in Fig. 3B ).
Pharmacological characterization of glycine transport currents:
In order to determine the pharmacological profile of glycine transport currents in Bergmann glia, the effects of substrate agonists, several competitive blockers of glycine transport and non transportable GlyT blockers were tested on strychnine-insensitive glycine-induced currents. Glycine and sarcosine, a substrate agonist of GlyT1, induced inward currents of similar amplitudes when pressure applied onto the same cells by using a theta glass pipette. The means of glycine-and sarcosine-induced currents were -43.7 ± 8.4 pA and -33.7 ± 5.8
pA, respectively (n=4, Fig. 4A ). When Na + was replaced by choline, sarcosine-induced inward currents were reversibly and completely blocked, identifying these currents as transport currents (n=5, Fig. 4B ).
The voltage-dependence of sarcosine-induced currents was strictly inwardly rectifying up to +50 mV and did not reverse as observed for glycine-induced transport currents (n=5, Fig. 4C and 4D ). Bath application of sarcosine (500 µM), which also acts as a competitive blocker of glycine transport through GlyT1 (Smith et al., 1992; Guastella et al., 1992; Liu et al., 1993; Lopez-Corcuera et al., 1998) , significantly (p<0.01) and reversibly reduced glycine-induced transport currents by 83.3 ± 2.4% (n=11, including 5 cells recorded with a low KCl solution, Fig. 4E ). By contrast, 100 µM amoxapine, which blocks glycine transport through GlyT2 by 40% without affecting transport through GlyT1 (Nunez et al., 2000) , did not affect glycine-induced currents (99.5 ± 0.9% of control, p>0.5) and did not induce any inward currents (n=5, data not shown). Next, we tested the effects of non-transportable blockers of GlyT1, NFPS (Atkinson et al., 2001; Aubrey & Vandenberg, 2001; Mallorga et al., 2003) , and of GlyT2, ORG 25543 (Compound 16 in Caulfield et al., 2001) , on glycine-induced transport currents. NFPS (5 µM, applied for 3 min prior to glycine application) significantly (p<0.01) and reversibly reduced glycine-induced transport currents by 87.0 ± 4.9% (from -40.4 ± 11.2 pA to -6.0 ± 5.1 pA, n=5 cells recorded with a low KCl solution, Fig. 4F ) while ORG 25543 (10-50 µM) had no effect (n=5, Fig. 4G ). NFPS was washed out for a minimum of 20 min. Glycine is also transported by low-affinity transport systems, namely system A and system ASC (Christensen, 1984; Palacin et al., 1998) and both systems have been shown to be expressed in glia (Zafra & Gimenez, 1989; Gadea et al., 1999 ). Therefore, we tested the effects of competitive blockers of system ASC (L-serine), system A (methylaminoisobutyric acid, MeAIB), and of both systems (L-alanine) (Barker & Ellory, 1990 ) on glycine-induced transport currents. None of these competitive blockers (each bath applied at 1 mM) affected glycine-induced transport currents (p>0.1, Fig. 5A , 5B and 5C, respectively, n=3 each). Together these data suggest that glycine is transported through GlyT1 in Bergmann glia. To check for GlyT1 selectivity to glycine, we tested the effects of taurine and GABA on glycine-induced transport currents in the presence of strychnine, picrotoxin and phaclofen to block glycine, GABA A/C , and GABA B receptor activations, respectively. Taurine and GABA are known to be taken up by taurine and GABA transporters, respectively, but not by glycine transporters (Guastella et al., 1992; Liu et al., 1992; Smith et al., 1992; Gadea & Lopez-Colome, 2001 ). Bath application of GABA or taurine each at 500 µM had no effect on glycine-induced transport currents (p>0.1, Fig. 5D and 5E, respectively, n=3 each), suggesting that glycine transport systems in Bergmann glia are selective for the inhibitory amino acid glycine. However, in the presence of GABA A/B/C receptor blockers, GABA and taurine, induced inward currents, which likely result from the electrogenic transport of these amino acids by their respective transporters expressed in Bergmann glia (Swan et al., 1994; Morara et al., 1996; . which is known to primarily account for E REV of GABA A receptors (Muller et al., 1994; Kyrozis & Reichling, 1995) . Gramicidin is an antibiotic that does not perturb the [Cl - ] gradient across the cell membrane (Myers & Haydon, 1972; Kyrozis & Reichling, 1995) . Recorded cells had a typical hyperpolarized resting potential of -82.9 ± 6.3 mV and a low input resistance of 39.6 ± 4.3 MΩ (after 35 min of recording). A ramp protocol was applied every 30 sec after formation of a gigaseal (data not shown). Once the ramp-induced currents had reached a steady state, 5 mM Ba 2+ was applied to block K + channels and 100 µM GABA or muscimol was pressure applied. E REV of GABA A responses were obtained by either applying a ramp near the peak of GABA A currents and then by subtracting ramps obtained during and before GABA applications ( Fig. 6A and 6B for responses induced by GABA), or by applying GABA or muscimol at different holding potentials (Fig. 6C ) and plotting the resulting I-V curves (Fig. 6D) . The mean E REV of GABA and muscimol responses was -39.3 ± 4.9 mV (n=7 (Staley et al., 1995) . (Rose & Ransom, 1996a) . To first test for glycine transport reversal we intracellularly perfused an intracellular solution containing 4 mM glycine + 12.5 mM Na + during the recording. Intracellular glycine and Na + concentrations were then about 2 mM and 12.5 mM, respectively (see "Materials and Methods"). This was performed at -50 mV to allow the development of an outward current upon internal glycine perfusion as previously observed for carrier-mediated taurine and GABA efflux currents . When cells were held at -50 mV, outward currents of +11.2 ± 0.6 pA (n= 3/3) developed upon intracellular perfusion of glycine (Fig. 7Aa) . After intracellular glycine perfusion, glycine uptake currents measured at -50 mV were significantly (p<0.002) decreased by 66 ± 4% (-22.0 ± 1.7 pA before and -7.6 ± 1.4 pA after intracellular glycine perfusion, n=4). When cells were held at -70 mV, intracellular perfusion of glycine did not induce any outward current but external glycine-induced inward currents were also significantly (p<0.02) decreased by 54.0 ± 1.1 % (-35.0 ± 6.9 pA before and -16.0 ± 3.5 pA after intracellular glycine perfusion, n=4, Fig. 7Ab ). This decrease in the amplitudes of glycine uptake currents was likely due to an intracellular competitive block of glycine uptake by glycine itself.
Carrier-mediated glycine efflux from Bergmann glia

GlyT reversal in Bergmann glia
Consistent with this idea, the decrease in the amplitudes of glycine uptake currents was not observed when internal perfusion of a glycine-free intracellular medium was performed (-18.6 ± 1.4 pA before and -18.5 ± 0.7 pA after intracellular glycine-free medium perfusion at a holding potential of -50 mV, n=3, p>0.9, Fig. 7Ac ). In addition, perfusion of a glycine-free solution did not induce outward currents at -50 mV as can be readily observed on the plot of the mean outward current amplitude as a function of time (Fig. 7B) . As a control of glycine intracellular perfusion, lucifer yellow was routinely added in the intracellularly perfused solution but not in the recording solution to confirm that the intracellularly perfused solution was diffusing into the cell during the recording. In all of these experiments, lucifer yellow had diffused into the cell (data not shown). To further observe glycine transport reversal, 40 mVincrement voltage steps of 150 ms were applied from -100 to +60 mV from a holding potential of -70 mV (protocol displayed under the traces in Fig. 7C ). In response to voltage steps Bergmann glia generated transient (capacitive) and steady-state currents (Fig. 7C, plain lines) . Intracellular perfusion of 4 mM glycine during the recording induced an increase in the steady-state currents without affecting capacitive currents (Fig. 7C, dotted lines) . Point-by-point subtraction of the currents in the presence and absence of intracellular glycine isolated outward currents (data not shown) whose mean I-V curves are displayed in Fig. 7D (n=3) .
In order to further determine whether glycine was released from Bergmann glia via GlyT1 reversal, we obtained outside-out membrane patches from granule cells and used glycine receptor channel activity as a sensor of extracellular glycine. We confirmed that granule cells express glycine receptors (Kaneda et al., 1995) Depolarizations of Bergmann glia from -70 to +20 mV for 2 sec induced an increase in single channel activity recorded in membrane patches of granule cells. When the membrane patches were >50 µm away from the recorded Bergmann glia, no change in the channel activity was detected (data not shown). After
Bergmann glial cell depolarization, the channel open probability (NP 0 ) significantly (p<0.02) increased by 73.1 ± 19.0% in 6 of 8 membrane patches of granule cells. Three minutes after 5 µM NFPS application, depolarizations of Bergmann glia had no significant effect on the open channel probability in granule cell membrane patches (105.0 ± 8.4 % of control, n=5, p>0.5). The single channels recorded in granule cell membrane patches were identified as glycine receptor channels because they were completely blocked by 100 µM strychnine (Fig. 8C ). GlyT1 in Bergmann glia can thus work in reverse and release glycine under near-physiological ionic and internal glycine conditions.
DISCUSSION
In the present study we report for the first time direct measurements and electrophysiological characterization of glycine transporter currents in glial cells recorded in a near-intact system, the cerebellar slice preparation. More specifically, our data show that: 1) Bergmann glia possess functional glycine transporters, the GlyT1 subtype, and 2) Bergmann glial GlyT1 can mediate electrogenic glycine efflux at and more depolarized than -50 mV.
Glycine transporters GlyT1 mediate glycine influx into Bergmann glia
In ~90% of the recorded Bergmann glia, glycine induced small inward currents. These glycine-induced currents were not affected by strychnine, an antagonist of glycine receptors, which indicates that glycine receptors are either not present or not functional in Bergmann glia. In addition, strychnine-insensitive glycine-induced currents resembled other Na + /Cl --dependent transporter currents (Barbour et al., 1990; Borden, 1996; , and were completely blocked by removal of external Na + and markedly diminished by external [Cl - ] reduction, identifying them as transport currents. In the absence of internal glycine the mean I-V curve of glycine transport currents was strictly inwardly rectifying, which differs from the small inward rectification observed for glycine transport currents recorded in occytes (Roux & Supplisson, 2000) . It is possible that in our recordings the amplitudes of glycine transport currents are too small for detection at membrane potentials >+20 mV.
Nevertheless, no outward currents could be detected at depolarized membrane potentials, as previously reported for GlyT currents recorded in oocytes (Roux & Supplisson, 2000) and other Na
transporter currents recorded in Bergmann glia . For all of these recordings, Bergmann glia were recorded in conditions to maximize the transport currents with low intracellular Na + and no glycine. At near-physiological ionic conditions in Bergmann glia (~30 mM internal [Cl - ] found in this study and in hippocampal astrocytes (Bekar & Walz, 2002) , and ~12.5 mM
, (Rose & Ransom, 1996a) However, the presence of 2 mM glycine in the internal solution reduced glycine-induced transport currents, which suggests that intracellular and extracellular glycine compete for transport and supports the conclusion that Na + -dependent transport currents induced by glycine are due to the uptake of glycine plus Na + into Bergmann glia. Pressure application of sarcosine induced Na + -dependent currents, suggesting the presence of GlyT1 transporters in Bergmann glia. Furthermore, two blockers of glycine transport through GlyT1, sarcosine and NFPS ( Smith et al., 1992; Liu et al., 1993; Guastella et al., 1992; Lopez-Corcuera et al., 1998) , reduced glycine transport currents by ~85%, consistent with the presence of positive GlyT1 immunostaining in Bergmann glial processes in this study, as previously reported (Zafra et al., 1995) . By contrast, blockers of glycine transport through GlyT2 did not affect glycine transport currents although GlyT2 staining was observed in presumed glial fibers in the molecular layer. GlyT2 immunostaining has not been reported in Bergmann glia but in glial elements of the cerebellar molecular layer (Zafra et al., 1995) . Because GlyT2 staining was sparse and essentially absent from glial cell bodies, it is quite possible that GlyT2 currents, if present, are too small for detection. The fact that sarcosine is a competitive inhibitor (Guastella et al., 1992; Lopez-Corcuera et al., 1998) and NFPS inhibition of GlyT1 is concentration and time dependent (Aubrey & Vandenberg, 2001 ) likely explain the lack of complete inhibition of glycine transport currents by sarcosine and NFPS. NFPS was applied for 3 minutes, which has been shown to not completely block GlyT1-mediated currents in oocytes (Aubrey & Vandenberg, 2001 ). The substrate agonists of system A and ASC, which are Na + -dependent transport systems and can mediate glycine uptake (Palacin et al., 1998) did not affect glycine transport currents. This indicates that glycine transport currents are mediated by Na + /Cl --dependent GlyTs and not by these other glycine transport systems. Altogether, these data suggest that glycine is transported into Bergmann glia essentially through GlyT1 transporters.
GlyTs in Bergmann glia can work in reverse at near-physiological ionic and internal glycine conditions.
To study glycine transport reversal, Bergmann glia were recorded at near physiological ionic conditions (32 mM internal [Cl - ], and ~12.5 mM internal [Na + ], Rose & Ransom, 1996a) . Upon intracellular glycine perfusion during the recording to obtain a final near-physiological intracellular glycine concentration of ~2 mM (Berger et al., 1977) , outward currents progressively developed when the cells were held at -50 mV but not at -70 mV. In addition, glycine uptake currents were significantly reduced in amplitude after intracellular glycine perfusion at -50 mV, which suggests that intracellular glycine influences the uptake of extracellular glycine, as previously reported for GlyT1 injected in Oocytes (Roux & Supplisson, 2000) .
These data suggest that GlyTs can work in reverse upon internal glycine perfusion and glial cell depolarization, which is in good agreement with previous studies on GlyT1 injected in oocytes (Roux & Supplisson, 2000) or expressed in HEK-293 cells (Sakata et al., 1997) . These data also suggest that glycine-induced outward currents are not unspecific leakage currents, consistent with a tight coupling between ionic and substrate fluxes (Roux & Supplisson, 2000) . The use of paired recordings of a Bergmann glial cell and a granule cell confirmed that glycine was released via GlyT1 when Bergmann glia were depolarized to +20 mV as the increase in the open probability of glycine receptor channels was prevented in the presence of NFPS in the bath. This is consistent with Roux and Supplisson (2000) 's finding that the GlyT1 subtype is well suited to mediate reverse glycine transport. Overall, we identified that at near-physiological internal Na + , Cl -and glycine concentrations glycine can be released via GlyT1
in Bergmann glia at a membrane potential of and more depolarized than -50 mV.
Functional implications of glycine uptake and release in Bergmann glia
GlyTs have been suggested to play an important regulatory role at glycine receptor-containing synapses by clearing glycine from the synaptic cleft and/or at NMDAR-containing synapses by locally keeping extracellular glycine levels below local saturating concentrations at the glycineB site on NMDARs (Wood, 1995; Parsons et al., 1998; Supplisson & Bergman, 1997; Gomeza et al., 2003a, b; Kinney et al., 2003; Chen et al., 2003) . In the cerebellum, mixed GABA and glycine receptors-containing synapses occur onto Golgi cell dendrites in the molecular and granule cell layers (Dumoulin et al., 2001) . However, it remains unknown whether Bergmann glial processes, which express GlyT1, encapsulate glycinergic synapses onto Golgi cell dendrites and regulate glycinergic synaptic transmission by removing glycine from the synaptic cleft. At the age studied functional NMDARs are not thought to be present in Purkinje neurons (Llano et al., 1991; Rosenmund et al., 1992) . However, they are expressed on presynaptic GABAergic axons and terminals synapsing onto Purkinje neurons and their tonic activation by ambient glutamate enhances spontaneous GABA release from these terminals (Glitsch & Marty, 1999; Huang & Bordey, 2004) . Presynaptic NMDARs have also been shown to be involved in long-term depression at synapses between parallel fibers and Purkinje neurons (Casado et al., 2002) .
Bergmann glia processes closely encapsulate inhibitory and excitatory synapses on Purkinje neuron soma and dendrites (Palay & Chan-Palay, 1974) . Thus, since Bergmann glia express functional GlyT1 as shown in our study and in previous immunohistochemical studies (Guastella et al., 1992; Zafra et al., 1995) , they are in a prime location to affect the function of NMDARs at both inhibitory and excitatory synapses.
Assuming that the glycineB site at these NMDARs is not saturated as shown in vivo in the cerebellum (Wood et al., 1989; Rao et al., 1990; Fedele et al., 1997) , in slices and in vivo in other brain regions (Bergeron et al., 1998; Supplisson & Bergman, 1997; Kinney et al., 2003; Chen et al., 2003) , and based on Roux and Supplisson (2000) 's calculations, glycine uptake into Bergmann glia might decrease tonic NMDAR activation, and reduce GABA release and long-term depression. It is important to consider that D-serine has been suggested to be the endogenous ligand of the glycineB sites in many CNS regions (Schell et al., 1997; Baranano et al., 2001 ). In the cerebellum, at the age studied glycine levels progressively increase while D-serine levels decrease (Schell et al., 1997; Miranda-Contreras et al., 1999) , suggesting that both glycine and D-serine are important ligands of NMDARs, with an increasing contribution of glycine during neonatal development.
Regarding non-vesicular glycine release its function remains unclear under physiological conditions.
Based on Roux and Supplisson (2000, see Figure 7 ), GlyT1 is close to equilibrium for an extracellular glycine concentration of 100 nM and a resting potential of -70 mV. In addition, our data indicate that glycine transporters can reverse at -50 mV upon intracellular glycine perfusion at near-physiological ionic conditions. It is then questionable whether Bergmann glia, whose resting potentials are between -80 and -90 mV, can be sufficiently depolarized by neuronal activity to promote glycine efflux. Non-vesicular glycine release via GlyT1 reversal may in fact occur under high frequency stimulation and likely under ischemic conditions. During high frequency stimulation (100 Hz), hippocampal astrocytes display synaptically-induced currents of ~1200 pA (Diamond & Jahr, 2000) . Depending on the cell resistance (between 5 to 200 MΩ) ( Bordey & Sontheimer, 1997; Diamond & Jahr, 2000) , astrocytes could be considerably depolarized. In addition, glutamate receptor activation triggers increases in intracellular Na + (Rose & Ransom, 1996b) , which combined with cell depolarizations may be sufficient to induce glycine transport reversal during high frequency stimulation. During ischemic conditions, glia are depolarized up to -50 mV and intracellular [Na + ] is estimated to rise to 39 mM (Attwell et al., 1993) . In addition, previous studies have shown Ca
2+
-independent glycine release in ischemic conditions in brain slices (Saransaari & Oja, 2001) . Assuming that the glycineB site is not saturated in the molecular and Purkinje cell layers, extracellular increased glycine levels could significantly contribute to the development of NMDAR-mediated excitotoxic damages.
Overall, our study of glial Na A. Glycine-induced currents were abolished by replacing external Na + with choline, identifying them as glycine transport currents. B. Glycine responses were reversibly diminished by reduction of external Cl -(11 mM instead of 136 mM). In (A) and (B) recordings were obtained at -70 mV. C. Glycine-induced currents recorded at different holding potentials from -70 to +50 mV. Theses currents inwardly rectified and did not reverse for positive membrane potentials. D. Mean current-voltage curve of glycine-induced inward currents (n=5). All of these experiments were performed in the presence of TTX and a glycine receptor blocker (100 µM strychnine) in the bath. Competitive blockers of system ASC (L-serine), system A (MeAIB), and of both systems (Lalanine)(each applied at 1 mM) had no effect on glycine-induced transport currents. D-E. Bath application of substrate agonists of GABA transporters (GABA) or of taurine transporters (taurine, each at 500 µM) had no effect on glycine-induced transport currents. For all of the experiments, glycine-induced currents were recorded in the presence of TTX and 100 µM strychnine in the bath at a holding potential of -70 mV. Inward current induced by a rapid bath application of 100 µM glycine in a granule cell recorded at a holding potential of -70 mV in the whole cell configuration. B. Single channel activity in outside-out patches of a granule cell during control and 15 s after depolarization of an adjacent Bergmann glial cell recorded in the whole-cell configuration. The Bergmann glial cells were depolarized from -70 to +20 mV for 2 s. Bottom, Single channel activity on an expanded time scale. C. Single channel activity in the membrane patch of a granule cell before and after depolarization of the simultaneously recorded Bergmann glial cell in the presence of the GlyT1 blocker, NFPS (100 µM), and during application of the glycine receptor blocker, strychnine (100 µM, bottom). NFPS was applied for 3 min before the glial cell depolarization. Middle, single channel activity on an expanded time scale. The same cell pair was recorded in B and C. All of the recordings in (A-C) were performed in the presence of blockers of GABAA receptors (20 µM SR95531), AMPA/kainate (20 µM NBQX) and NMDA receptors (20 µM D-APV). C=closed
